•
Sep 30, 2021

Selecta Biosciences Q3 2021 Earnings Report

Total Revenue
$24.4M
Previous year: $4.65M
+425.8%
EPS
-$0.16
Previous year: -$0.09
+77.8%
Gross Profit
$24.4M
Previous year: $4.65M
+425.8%
Cash and Equivalents
$115M
Previous year: $146M
-21.6%
Free Cash Flow
-$10.9M
Previous year: $65.3M
-116.7%
Total Assets
$167M
Previous year: $181M
-7.6%

Selecta Biosciences

Selecta Biosciences